Metabiota Stock

metabiota.comHealthcare / Healthcare providers & servicesFounded: 2008Funding to Date: $84.22MM

Metabiota is a health big data tracking company providing data, analytics, advice, and training to help governments prepare for global health threats and mitigate their impacts.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to Metabiota before its M&A, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Metabiota Stock Price

Forge Price 1
Price not available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

Metabiota Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
03/07/2017 Series B $8.02MM $xx.xx $156.11MM In-Q-Tel, Sharespost, Wp Global Partners
Price per Share
$xx.xx
Shares Outstanding
4,358,880
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.3x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
In-Q-Tel, Sharespost, Wp Global Partners
05/21/2015 Series A $31.2MM $xx.xx $89MM Capricorn Healthcare, Capricorn Investment Group, Google Ventures, Industry Ventures, Rosemont Seneca Technology Partners, Sharespost, The Data Collective, Wp Global Partners
Price per Share
$xx.xx
Shares Outstanding
21,603,654
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Capricorn Healthcare, Capricorn Investment Group, Google Ventures, Industry Ventures, Rosemont Seneca Technology Partners, Sharespost, The Data Collective, Wp Global Partners
12/24/2013 Series Seed $2.88MM $xx.xx $17MM Rosemont Seneca Technology Partners (Rstp), Tao Venture Capital Partners, The Data Collective & Other Investors
Price per Share
$xx.xx
Shares Outstanding
7,591,990
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Rosemont Seneca Technology Partners (Rstp), Tao Venture Capital Partners, The Data Collective & Other Investors

Metabiota Investors Also Invested in These Private Companies

Leadership & Board

Leadership

Robert Mann
COO & President
Nathan Wolfe
Founder & Chairman
James Pitkow Ph.D
CTO
Michael Bell
CFO
Mary Guttieri Ph.D
Executive Vice President

Board

Nathan Wolfe
Metabiota
John DeLoche
RSTP
Riaz Valani
Self

Metabiota stock FAQs

plusminus

Can you buy Metabiota stock?

You can no longer buy Metabiota stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

How to buy Metabiota stock?

You can no longer buy Metabiota stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

Can you sell Metabiota stock?

You can no longer sell stock of Metabiota on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

How to sell Metabiota stock?

You can no longer sell stock of Metabiota on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

Is Metabiota a public company?

Metabiota is now a public company.
plusminus

What is Metabiota’s stock price?

The stock price of Metabiota is not currently available.
plusminus

What is Metabiota’s stock ticker symbol?

The ticker symbol of Metabiota is not currently available.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Metabiota News and Media Highlights

Want to know where epidemics are flaring up around the world? Metabiota has the tool for you

In an effort to inform the public of the health risks breaking out all over the world (or just to scare the bejeezus out of already paranoid people), the startup Metabiota has released a free-to-use epidemic tracker for all of the outbreaks monitored publicly around the world. The San Francisco-bas…

ARC and Metabiota begin parametric outbreak & epidemic insurance pilot | Artemis.bm

The African Risk Capacity (ARC), a parametric sovereign disaster risk insurer for African nations, has begun a pilot with the help of San Francisco based Metabiota to roll-out parametric insurance cover against disease outbreaks and epidemics. The new parametric outbreak & epidemic insurance product has been coming for some time, as ARC looks to expand its remit to cover new risks which will in turn increase the diversification within and efficiency of its sovereign risk pool. Metabiota is a company focused on risk analytics for epidemics and it has just begun the risk modelling work for the new ARC outbreak and epidemic insurance product. The goal is to help African Nations to better plan for and mitigate the risk of infectious disease outbreaks within their countries, providing an insurance product that will pay out rapidly should an outbreak show signs of developing, helped by the use of parametric triggers and backed by global reinsurance capacity. The pilot phase of the

With a new CEO, Metabiota looks to new markets for its epidemic monitoring toolkit

Bill Rossi, the new chief executive officer at Metabiota, believes that (unlikely as it seems) the insurance industry might be the key to stopping epidemic..
Browse Insights
Updated on: Dec 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.